We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BODI icon
3701
The Beachbody Company
BODI
$72.3M
$1.55K ﹤0.01%
187
-1
-0.5% -$11
PDLI
3702
DELISTED
PDL BioPharma, Inc.
PDLI
$1.51K ﹤0.01%
612
SOLO
3703
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$1.51K ﹤0.01%
4,500
DOMA
3704
DELISTED
Doma Holdings, Inc.
DOMA
$1.5K ﹤0.01%
325
CIAN
3705
DELISTED
Cian PLC American Depositary Shares, each representing one Ordinary Share
CIAN
$1.46K ﹤0.01%
430
AXR icon
3706
AMREP Corp
AXR
$117M
$1.45K ﹤0.01%
66
BRLT icon
3707
Brilliant Earth
BRLT
$19.7M
$1.44K ﹤0.01%
386
FTK icon
3708
Flotek Industries
FTK
$1.32B
$1.43K ﹤0.01%
366
CRVS icon
3709
Corvus Pharmaceuticals
CRVS
$1.17B
$1.39K ﹤0.01%
791
STG
3710
Sunlands Technology
STG
$47.5M
$1.37K ﹤0.01%
135
CAMP
3711
DELISTED
CalAmp Corp.
CAMP
$1.35K ﹤0.01%
235
EGIO
3712
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.35K ﹤0.01%
98
BDRX
3713
Biodexa Pharmaceuticals
BDRX
$1.51M
0
CODX
3714
Co-Diagnostics
CODX
$5.23M
$1.29K ﹤0.01%
32
SOND
3715
DELISTED
Sonder
SOND
$1.29K ﹤0.01%
381
XIN
3716
DELISTED
Xinyuan Real Estate
XIN
$1.28K ﹤0.01%
470
CLSD
3717
DELISTED
Clearside Biomedical
CLSD
$1.28K ﹤0.01%
73
BDTX icon
3718
Black Diamond Therapeutics
BDTX
$110M
$1.26K ﹤0.01%
449
WAVE
3719
Eco Wave Power Global
WAVE
$43.4M
$1.26K ﹤0.01%
1,015
AIRG icon
3720
Airgain
AIRG
$74.7M
$1.22K ﹤0.01%
343
DCBO
3721
Docebo
DCBO
$520M
$1.21K ﹤0.01%
25
GROW icon
3722
US Global Investors
GROW
$38.5M
$1.18K ﹤0.01%
417
GRFX
3723
DELISTED
Graphex Group
GRFX
$1.15K ﹤0.01%
264
XHG
3724
XChange TEC
XHG
$49.1M
$1.14K ﹤0.01%
1
HBM icon
3725
Hudbay
HBM
$11.7B
$1.13K ﹤0.01%
205

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.